Atlas Trials

Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Clinical trial NCT01008462 · COMPLETED

Trial details

NCT number
NCT01008462
Sponsor
Fred Hutchinson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
B-Cell Prolymphocytic LeukemiaHypodiploidyLoss of Chromosome 17pPlasma Cell LeukemiaProgression of Multiple Myeloma or Plasma Cell LeukemiaRecurrent Adult Hodgkin LymphomaRecurrent Adult Non-Hodgkin LymphomaRecurrent Childhood Hodgkin LymphomaRecurrent Childhood Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Plasma Cell MyelomaRecurrent Small Lymphocytic Lymphoma
Start date
2010-03-18
Primary completion
2018-06-30
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.